Opthea on the brink after Phase-3 failure
Australia’s visionary eye-health company Opthea, which raised almost $1 billion to bring its eye injection to market, is fighting for survival today after the failure of its first Phase-3 trial.
Mark Whittaker
Drop the co-pilot. Agentic AI now at the helm, says Salesforce
More than 10,000 people flocked to Salesforce’s Agentforce World Tour Sydney on Wednesday to hear about artificial intelligence’s newest era.
‘Google for ESG’: Fair Supply raises $12m to date to take on the world
Carbon emissions are the easy part. Fair Supply also wants to find the endangered frogs and the enslaved people in your supply chain.
8 wellness entrepreneurs reveal their health resolutions for 2025
Even those whose lives are devoted to the wellness of others can struggle to keep their own goals on track. Here’s what eight wellness entrepreneurs are setting their focus on in the new year.
Tracksuit dacks the market research incumbents
Brand tracking start-up Tracksuit claims to have hit a million dollars of revenue from both the UK and the US as it spends the $20m raised at a valuation of $143m early this year.
Nourish ferments deal with China to brew vegan animal fat
A Canberra-based biotech has teamed up with a Chinese fermenter produce its vegan “animal-fat” analogue product in Wuhan, just as last week’s US elections herald an administration hostile to both China and fake meat.
Fast-bowling skipper backs fast-growing Mountain Culture
Australian cricket captain Pat Cummins becomes first outside investor in booming boutique brewer going for its hat-trick of venues Pat Cummins was buying Mountain Culture beer out of his own pocket, they swear, but he’s now dug deeper into those pockets to buy a slice of the local company that’s enjoyed an extraordinary spell of […]
The skills that Shane Watson learned to overcome death and save his career
He was the highest paid cricketer in Australia until the death of a friend let the demons loose in his head – and almost ended his career. He’s now teamed up with SafetyCulture to teach people how he got his mojo back.
DefendTex: Why can’t we make guided missiles in Australia?
What the military wants and what it needs are two different things, says the DefendTex founder who wants to make guided-missiles in Australia.
Professor got nothing from the $2.8b sale of his molecule, and that’s okay
Discovering a cancer-busting molecule opened the door for PM’s prize-winning scientist Andrew Wilks’ next career as an entrepreneur and venture capitalist making killer returns.